153 related articles for article (PubMed ID: 32653978)
1. Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.
Mohammadian J; Mahmoudi S; Pourmohammad P; Pirouzpanah M; Salehnia F; Maroufi NF; Samadi N; Sabzichi M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2315-2323. PubMed ID: 32653978
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-Loaded Nanostructured Lipid Carrier (NLC): A New Strategy for Enhancing Efficacy of Doxorubicin in Breast Cancer Treatment.
Sabzichi M; Mohammadian J; Mohammadi M; Jahanfar F; Movassagh Pour AA; Hamishehkar H; Ostad-Rahimi A
Nutr Cancer; 2017; 69(6):840-848. PubMed ID: 28742387
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis.
Khaki-Khatibi F; Ghorbani M; Sabzichi M; Ramezani F; Mohammadian J
Biomed Pharmacother; 2019 Jan; 109():1240-1248. PubMed ID: 30551374
[TBL] [Abstract][Full Text] [Related]
4. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
5. Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy.
Yeo S; Wu H; Yoon I; Lee WK; Hwang SJ
Int J Pharm; 2024 May; 657():124048. PubMed ID: 38537925
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
Cao C; Wang Q; Liu Y
Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562
[No Abstract] [Full Text] [Related]
7. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
8. Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator.
Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
J Liposome Res; 2020 Mar; 30(1):21-36. PubMed ID: 30741049
[TBL] [Abstract][Full Text] [Related]
9. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
10. Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers.
Zheng S; Nguyen VD; Song SY; Han J; Park JO
Nanotechnology; 2017 Oct; 28(43):435102. PubMed ID: 28783035
[TBL] [Abstract][Full Text] [Related]
11. Layer-by-Layer Assembled Nanostructured Lipid Carriers for CD-44 Receptor-Based Targeting in HIV-Infected Macrophages for Efficient HIV-1 Inhibition.
Mahajan K; Rojekar S; Desai D; Kulkarni S; Bapat G; Zinjarde S; Vavia P
AAPS PharmSciTech; 2021 Jun; 22(5):171. PubMed ID: 34100170
[TBL] [Abstract][Full Text] [Related]
12. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
Li H; Chen M; Su Z; Sun M; Ping Q
Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of all-trans-retinoic acid-loaded biocompatible precirol: A strategy for escaping dose-dependent side effects of doxorubicin.
Sabzichi M; Mohammadian J; Ghorbani M; Saghaei S; Chavoshi H; Ramezani F; Hamishehkar H
Colloids Surf B Biointerfaces; 2017 Nov; 159():620-628. PubMed ID: 28865358
[TBL] [Abstract][Full Text] [Related]
14. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
[TBL] [Abstract][Full Text] [Related]
15. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
Pan Y; Zhou F; Zhang R; Claret FX
PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
17. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
18. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.
Xu G; Zhu L; Wang Y; Shi Y; Gong A; Wu C
Biomed Res Int; 2017; 2017():1832494. PubMed ID: 29226125
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
Liu Q; Li J; Pu G; Zhang F; Liu H; Zhang Y
Drug Deliv; 2016 May; 23(4):1364-8. PubMed ID: 25874959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
